Somatrogon
ATC H01AC08 · 9 markets · 20 records
AU 5 records · 5 strengths
- 60 mg/1.2 mLinjectionNgenla
- 24 mg/1.2 mLinjectionNgenla
- 50 mg/mLinjectionNGENLA somatrogon 24 mg solution for injection cartridge in prefilled pen
- 20 mg/mLinjectionNGENLA somatrogon 24 mg solution for injection cartridge in prefilled pen
Records without a stated strength · 1 Ngenla
US 2 records · 2 strengths
GB 2 records · 2 strengths
- 60 mg/1.2 mLinjectionNgenla 24mg/1.2ml solution for injection pre-filled pens
- 24 mg/1.2 mLinjectionNgenla 24mg/1.2ml solution for injection pre-filled pens
CA 2 records · 2 strengths
SG 2 records · 2 strengths
- 60 mg/1.2 mLinjectionNGENLA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 24 MG/1.2ml
- 24 mg/1.2 mLinjectionNGENLA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 24 MG/1.2ml
ES 2 records · 2 strengths
- 60 mg/1.2 mLinjectionNGENLA PRECARGADA
- 24 mginjectionNGENLA PRECARGADA
TW 2 records · 2 strengths
- 24 mginjectionNGENLA solution for injection in pre-filled pen 60 mg能增樂預填充注射筆24毫克
- 60 mginjectionNGENLA solution for injection in pre-filled pen 60 mg能增樂預填充注射筆60毫克
HK 2 records · 1 strengths
Records without a stated strength · 1 NGENLA solution for injection in pre-filled pen 60 mg
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Ngenla
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 60 mg/1.2 mL injection | Ngenla | Ngenla 24mg/1.2ml solution for injection pre-filled pens | Ngenla | NGENLA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 24 MG/1.2ml | NGENLA PRECARGADA | ||||
| 24 mg/1.2 mL injection | Ngenla | Ngenla 24mg/1.2ml solution for injection pre-filled pens | Ngenla | NGENLA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 24 MG/1.2ml | |||||
| 24 mg injection | NGENLA PRECARGADA | NGENLA solution for injection in pre-filled pen 60 mg 能增樂預填充注射筆24毫克 | |||||||
| 60 mg injection | NGENLA solution for injection in pre-filled pen 60 mg 能增樂預填充注射筆60毫克 | ||||||||
| 50 mg liquid | Ngenla | ||||||||
| 20 mg liquid | Ngenla | ||||||||
| 50 mg/mL injection | NGENLA somatrogon 24 mg solution for injection cartridge in prefilled pen | ||||||||
| 20 mg/mL injection | NGENLA somatrogon 24 mg solution for injection cartridge in prefilled pen | ||||||||
unknown | Ngenla | NGENLA solution for injection in pre-filled pen 60 mg | Ngenla |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in CA and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 CA 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.